Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. (Q48598106)

13 February 2018

title

Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. (English)

1 reference

13 February 2018

13

Vokes EE

1 reference

13 February 2018

author name string

Kowalczuk A

1

1 reference

13 February 2018

Macdonald RL

2

1 reference

13 February 2018

Amidei C

3

1 reference

13 February 2018

Dohrmann G 3rd

4

1 reference

13 February 2018

Erickson RK

5

1 reference

13 February 2018

Hekmatpanah J

6

1 reference

13 February 2018

Krauss S

7

1 reference

13 February 2018

Krishnasamy S

8

1 reference

13 February 2018

Masters G

9

1 reference

13 February 2018

Mullan SF

10

1 reference

13 February 2018

Mundt AJ

11

1 reference

13 February 2018

Sweeney P

12

1 reference

13 February 2018

Weir BK

14

1 reference

13 February 2018

Wollman RL

15

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

13 February 2018

published in

Neurosurgery

1 reference

13 February 2018

volume

41

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

page(s)

1028-36; discussion 1036-8

1 reference

13 February 2018

Audit in the management of gliomas.

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Radiation response and survival time in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Accelerated hyperfractionated radiotherapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Survival after stereotactic biopsy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Does the extent of surgery make a difference in high grade malignant astrocytoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Stereotactic radiosurgery for recurrent malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The fallacy of the localized supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The new WHO classification of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Computerized tomography in the prognosis of malignant cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-199711000-00004

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0014-2964(78)90100-7

Identifiers

DOI

10.1097/00006123-199711000-00004

1 reference

13 February 2018

PubMed ID

9361056

1 reference

13 February 2018